Newsfeeds - Spark Newswire

1 minute read

News

Affimed Announces New Innate Cell Engager AFM28 Targeting CD123 To Treat Acute Myeloid Leukemia

Today, 6:46 AM

Derived from Affimed’s ROCK® platform, AFM28 binds selectively and with high affinity the surface antigens CD123 and CD16A AFM28 shows better killing of primary leukemic blasts in comparison to monoclonal

AFMD

8 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For October 21, 2021

By Benzinga Insights

Today, 6:46 AM

Upgrades

AFMD

1 minute read

Truist Securities Initiates Coverage On Affimed with Buy Rating, Announces Price Target of $10

By Benzinga Newsdesk

Today, 6:46 AM

Truist Securities analyst Srikripa Devarakonda initiates coverage on Affimed (NASDAQ:AFMD) with a Buy rating and announces Price Target of $10.

AFMD

1 minute read

SVB Leerink Maintains Outperform on Affimed, Lowers Price Target to $12

By Benzinga Newsdesk

Today, 6:46 AM

SVB Leerink analyst Daina Graybosch maintains Affimed (NASDAQ:AFMD) with a Outperform and lowers the price target from $13 to $12.

AFMD

12 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 30, 2021

By Benzinga Insights

Today, 6:46 AM

Upgrades

AANNF

1 minute read

Stifel Initiates Coverage On Affimed with Buy Rating, Announces Price Target of $12

By Benzinga Newsdesk

Today, 6:46 AM

Stifel analyst Bradley Canino initiates coverage on Affimed (NASDAQ:AFMD) with a Buy rating and announces Price Target of $12.

AFMD

5 minute read

The Daily Biotech Pulse: MacroGenics’ Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA’s FDA Nod

By Shanthi Rexaline

Today, 6:46 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7)

ADIL

2 minute read

Earnings Scheduled For September 8, 2021

By Benzinga Insights

Today, 6:46 AM

Companies Reporting Before The Bell • Nanobiotix (NASDAQ:NBTX) is likely to report earnings for its first quarter. • Waterdrop (NYSE:WDH) is expected to report earnings for its second quarter.

ABM

3 minute read

The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week

By Shanthi Rexaline

Today, 6:46 AM

Biotech stocks extended their gains in the week ending Sept. 3, partly aided by the broader market strength. The news flow was fairly light ahead of the Labor Day holiday weekend.

AFMD

1 minute read

Earnings Scheduled For July 1, 2021

By Benzinga Insights

Today, 6:46 AM

Companies Reporting Before The Bell • Simply Good Foods (NASDAQ:SMPL) is projected to report quarterly earnings at $0.29 per share on revenue of $244.29 million.

AFMD